0000000000450055

AUTHOR

Mario Spatafora

showing 51 related works from this author

PS01.04 International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results

2021

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyChemotherapyOncologybusiness.industrymedicine.medical_treatmentInternal medicinemedicinebusinessAdjuvantJournal of Thoracic Oncology
researchProduct

Lung Compartmentalization of Increased TNF Releasing Ability by Mononuclear Phagocytes in Pulmonary Sarcoidosis

1989

The TNF is a monokine with cytotoxic and tumor-necrosing activities; in addition, TNF may play a role in inflammatory processes. The present study evaluates spontaneous and LPS-mediated release of TNF by AMs and autologous peripheral BMs of normal subjects and patients with pulmonary sarcoidosis. A recently developed cytotoxicity assay, specific for detection of TNF activity, was applied. This study demonstrates that (1) unstimulated mononuclear phagocytes released low levels of TNF with no differences between groups; (2) when effector cells were stimulated with LPS, AMs from patients with active pulmonary sarcoidosis released more TNF than AMs recovered from normal subjects and from patien…

AdultLung DiseasesMalePulmonary and Respiratory MedicineSarcoidosisCritical Care and Intensive Care MedicinePathogenesisHumansMedicineMacrophageLungLungTumor Necrosis Factor-alphabusiness.industryMacrophagesRespiratory diseaseMononuclear phagocyte systemCytotoxicity Tests Immunologicmedicine.diseasePulmonary AlveoliMonokinemedicine.anatomical_structureImmunologyLeukocytes MononuclearFemaleTumor necrosis factor alphaSarcoidosisCardiology and Cardiovascular MedicinebusinessBronchoalveolar Lavage FluidChest
researchProduct

Cytotoxic lymphocytes show reduced expression of cd94/NKG2A and perforin in malignant pleural effusions

2008

PleuritisSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Effect of indomethacin on the kinetics of tumour necrosis factor alpha release and tumour necrosis factor alpha gene expression by human blood monocy…

1991

Summary In this investigation we have examined the effects of indomethacin, an inhibitor of the cyclooxygenase pathway of arachidonic acid, upon the kinetics of the release of tumour necrosis factor alpha (TNF) and of the expression of TNF gene by lipopolysaccharide (LPS)-stimulated human blood monocytes (BM). Following stimulation of BM with LPS, TNF was released within 2 h, reached peak values at 8 h and declined at subsequent time-points (24 and 48 h). Indomethacin (10−5 m ) slightly stimulated the production of TNF at 2, 4, and 8 h and prevented the decline of TNF observed at 24 and 48 h. This effect was related to the persistence of TNF synthesis, as demonstrated by kinetics evaluation…

LipopolysaccharidesTranscription GeneticLipopolysaccharideNeutrophilsmedicine.medical_treatmentIndomethacinProstaglandinIn Vitro TechniquesPharmacologyDinoprostoneCyclooxygenase pathwaychemistry.chemical_compoundGene expressionmedicineHumansRNA MessengerPharmacologyTumor Necrosis Factor-alphabusiness.industryMonocyteKineticsmedicine.anatomical_structureCytokineGene Expression RegulationchemistryImmunologyIndicators and ReagentsArachidonic acidTumor necrosis factor alphabusinessPharmacological Research
researchProduct

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STE…

2011

Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combination of gemcitabine (Gem) with vinorelbine (Vin), etoposide (Eto), cisplatin (Cis), or carboplatin (Car). Gemcitabine dose was the same (1000 mg/m2, days 1-8) in all combinations. A two-stage minimax flexible design for response was applied to GemVin combination (Vin 25 mg/m2, days 1-8). For GemCar, GemCis, GemEto, a phase I-II Bayesian design was applied, looking for the optimal dose of the partner drugs. Objective response rate ≥60% and un…

OncologyMaleLung NeoplasmsDeoxycytidineCarboplatinchemistry.chemical_compoundElderlyAntineoplastic Combined Chemotherapy Protocols80 and overCarcinoma Small CellMultivariate AnalysiEtoposideEtoposidePlatinum compoundsAged 80 and overArea under the curveSCLCVinorelbinePrognosisElderly; Etoposide; Gemcitabine; Platinum compounds; SCLC; Vinorelbine; Aged; Aged 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma Small Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Multivariate Analysis; Prognosis; Proportional Hazards Models; Quality of Life; Treatment Outcome; Vinblastine; VinorelbineTreatment OutcomeOncologyPlatinum compoundToxicityFemalemedicine.drugHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyPrognosiVinorelbineVinblastineDisease-Free SurvivalInternal medicinemedicineHumansAgedProportional Hazards ModelsCisplatinAntineoplastic Combined Chemotherapy ProtocolPerformance statusbusiness.industryCarcinomaSmall CellGemcitabineGemcitabineCarboplatinSurgeryLung NeoplasmchemistryMultivariate AnalysisProportional Hazards ModelQuality of LifeCisplatinbusiness
researchProduct

Tumori polmonari

2006

researchProduct

Antitumour activity of mononuclear phagocytes: role of tumour necrosis factor alpha.

1992

Tumour necrosis factor alpha (TNF) is a cytokine produced by mononuclear phagocytes (MP) originally discovered for its cytotoxic activity on tumour cell targets. It was subsequently demonstrated that, in addition to its oncolytic potential, TNF exerts a wide variety of activities on the host defensive system against malignancies. This article briefly reviews the current concepts on the role of TNF in the antitumour activity of MP.

Pulmonary and Respiratory MedicineCytotoxicity ImmunologicPhagocytesbusiness.industryTumor Necrosis Factor-alphamedicine.medical_treatmentCellTumour necrosis factor alphaOncolytic virusKiller Cells NaturalMajor Histocompatibility ComplexCytokinemedicine.anatomical_structureNeoplasmsImmunologymedicineCytotoxic T cellHumansTumor necrosis factor alphabusinessRespiration; international review of thoracic diseases
researchProduct

Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): A multicentre phase II clinical trial

2001

Abstract A phase II study in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) was carried out to evaluate the clinical activity and toxicity of the chemotherapeutic combination of gemcitabine+vinorelbine (GEM/VNR). Forty-five patients (40 male, 5 female) with a median age of 67 years (range 37–73) and a median ECOG performance status of 1 (range 0–2) were enrolled into the trial. Twenty patients had stage IIIB (two positive supraclavicular nodes and 20 cytologically positive pleural effusion), and 25 had stage IV NSCLC. GEM 1000 mg/m 2 diluted in 250 cc 3 of normal saline was administered iv on days 1, 8, and 15, while VNR was given 30 mg/m 2 on days 1 and 8 every 4 weeks. The…

Pulmonary and Respiratory MedicineAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsNeutropeniaPleural effusionmedicine.drug_classnon-small cell lung cancer (NSCLC)Phases of clinical researchNeutropeniaVinorelbineVinblastineGastroenterologyAntimetaboliteDeoxycytidineInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansInfusions IntravenousAgedbusiness.industryVinorelbineMiddle Agedmedicine.diseaseSurvival AnalysisGemcitabineGemcitabineSurgeryRegimenTreatment OutcomeOncologyInjections IntravenousFemalebusinessmedicine.drug
researchProduct

Studio multicentrico di III fase in pazienti affetti da carcinoma polmonare non a piccole cellule in stadio IV non precedentemente chemiotrattati

2006

researchProduct

Lung cancer: does age affect treatment strategy?

2009

Oncologymedicine.medical_specialtybusiness.industryInternal medicinemedicineTreatment strategyLung cancer elderlySettore MED/10 - Malattie Dell'Apparato RespiratoriobusinessAffect (psychology)Lung cancermedicine.disease
researchProduct

Invecchiamento, stress ossidativo e funzione polmonare

2006

researchProduct

Lung penetration and patient adherence considerations in the management of asthma: role of extra fine formulations

2013

The mainstay of management in asthma is inhalation therapy at the target site, with direct delivery of the aerosolized drug into the airways to treat inflammation and relieve obstruction. Abundant evidence is available to support the concept that inflammatory and functional changes at the level of the most peripheral airways strongly contribute to the complexity and heterogeneous manifestations of asthma. It is now largely accepted that there is a wide range of clinical phenotypes of the disease, characterized primarily by small airways involvement. Thus, an appropriate diagnostic algorithm cannot exclude biological and functional assessment of the peripheral airways. Similarly, achievement…

Pulmonary and Respiratory MedicineDrugmedicine.medical_specialtyPathologymedia_common.quotation_subjectDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioQuality of life (healthcare)Asthma controlJournal of Asthma and AllergymedicineImmunology and AllergyIntensive care medicinedeviceOriginal Researchmedia_commonAsthmasmall airwaysLungInhalationbusiness.industrySmall airwaysasthmarespiratory systemmedicine.diseaserespiratory tract diseasesmedicine.anatomical_structurequality of lifeinflammationCorrigendumbusinessJournal of Asthma and Allergy
researchProduct

Phase III study in patients with stage IV non small cell lung cancer treated with two cycles of cisplatin/gemcitabine followed by a randomization to …

2005

researchProduct

La terapia con broncodilatatori nel paziente anziano

2007

researchProduct

Diagnosis of a Case of Lipoid Pneumonia by Bronchoalveolar Lavage

1987

Exogenous lipoid pneumonia (ELP) was diagnosed by bronchoalveolar lavage (BAL) in a 57-year-old woman with a long history of using oily nose drops. Since clinical and roentgenological presentations are nonspecific, BAL, along with specific staining of recovered alveolar macrophages, represents a safe alternative to more invasive diagnostic procedures whenever a diagnosis of ELP is suspected.

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyNose DropsPneumonia AspirationmedicineHumansMineral OilSpecific stainingBronchusLungmedicine.diagnostic_testbusiness.industryMacrophagesRespiratory diseaseMiddle Agedrespiratory systemmedicine.diseasePneumonia Lipidrespiratory tract diseasesPulmonary AlveoliPneumoniamedicine.anatomical_structureBronchoalveolar lavageFemaleExogenous lipoid pneumoniabusinessBronchoalveolar Lavage FluidRespiration
researchProduct

Automatic bilevel ventilation in sleep-disordered breathing: A real-life experience in southern Italy

2016

Automatic bilevel ventilation (AutoBI) has been recently introduced to treat obstructive sleep-disordered breathing (SDB), but clinical experience is still limited. We revised the charts of patients treated for obstructive SDB in our sleep clinic in 2015 (n=214) to assess the frequency of trials of AutoBI ventilators (ResMed Auto25 or Respironics BiFlex), the clinical characteristics of these patients, the reason to shift from CPAP to AutoBI, and the outcome of AutoBI titration. A trial of domiciliary AutoBI was made in 44 patients (20.5%) intolerant to CPAP due to high CPAP levels (n=11) or who showed incomplete resolution of SDB on CPAP (n=33). The table reports the clinical data accordin…

COPDPediatricsmedicine.medical_specialtyExtreme obesitybusiness.industrymedicine.diseaseAlternative treatmentnervous system diseasesrespiratory tract diseasesBreathingmedicineSleep disordered breathingArterial bloodIn patientbusiness4.2 Sleep and Control of Breathing
researchProduct

Mononuclear Cells in Exudative Malignant Pleural Effusions

1994

The aims of this study were to develop a methodology for the isolation of highly enriched mononuclear phagocyte populations from exudative malignant pleural effusions (EMPE) and to characterize the phenotype and functional properties of these cells. Pleural effusion mononuclear cells (PEMC) were isolated by Ficoll centrifugation of EMPE and transudative pleural effusions and allowed to adhere to plastic for 1 h to obtain a pleural effusion mononuclear adherent cell (PEMAC) fraction. Only 66.0±4.2 percent of PEMAC ingested latex particles, indicating that a significant proportion of PEMAC were not phagocytic cells. Latex-positive PEMAC had the morphologic appearance of macrophages and staine…

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtybusiness.industryPleural effusionCD14InterleukinMononuclear phagocyte systemCritical Care and Intensive Care Medicinemedicine.diseasePeripheral blood mononuclear cellProinflammatory cytokineAntigenMedicineTumor necrosis factor alphaCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Correlates of Energy Expenditure and Sedentary Life in Free-Living COPD.

2006

researchProduct

Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients.

2003

Questionnaires are the most used subjective instrument of measurement in respiratory epidemiology. The standardisation of the questionnaires aims to limit bias by maximising validity and reliability, and comparability. Within the European Union project BIOMED1, a compendium of respiratory standard questionnaires (CORSQ) was developed for adults covering 18 topics from general information to early life events, through environmental risk factors and respiratory symptoms and diseases. Reliable spirometry data needs a rigorous quality control programme, as in the "Salute Respiratoria nell'Anziano" (Sa.R.A.) project, Italian for "Respiratory Health in the Elderly". Reproducibility rates were 95.…

Pulmonary and Respiratory MedicineSpirometryAdultMalemedicine.medical_specialtypeak expiratory flowRespiratory Tract DiseasesMEDLINEValidityPeak Expiratory Flow RateSettore MED/10 - Malattie Dell'Apparato RespiratorioElderlyReference ValuesRisk FactorsAir PollutionSurveys and QuestionnairesEpidemiologyElderly peak expiratory flow questionnaires reference values spirometryMedicinemedia_common.cataloged_instanceHumansReference ValueEuropean unionRespiratory Tract DiseaseReliability (statistics)media_commonAgedmedicine.diagnostic_testbusiness.industryRisk FactorRespiratory diseaseCognitionquestionnairesmedicine.diseaseEpidemiologic StudieSurgeryEpidemiologic StudiesSpirometryPhysical therapyFemalebusinessHumanThe European respiratory journal. Supplement
researchProduct

Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study

2015

Background: In outpatients with chronic obstructive pulmonary disease (COPD), blood eosinophilia is considered as a biomarker of response to systemic corticosteroid therapy. However, little is known on whether blood eosinophilia is also predictive of positive clinical outcome in severe acute exacerbations of COPD requiring hospitalization. We hypothesized that blood eosinophil-positive severe acute exacerbations of COPD differ from eosinophil-negative ones in terms of response to therapy and clinical outcomes. Methods: To test our experimental hypothesis, we retrospectively analyzed medical records of patients with COPD admitted to our ward because of severe exacerbation, over a two-year pe…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyEosinophilSettore MED/10 - Malattie Dell'Apparato RespiratorioSeverity of Illness IndexdosageGlucocorticoids/administration &ampPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineEosinophiliaSeverity of illnessmedicineHumansBiological markers/bloodCOPDEosinophiliaPharmacology (medical)030212 general & internal medicineIntensive care medicineAgedRetrospective StudiesAged 80 and overCOPDbusiness.industryMedical recordBiochemistry (medical)Case-control studyRetrospective cohort studyMiddle Agedmedicine.diseaserespiratory tract diseasesEosinophilsHospitalizationTreatment Outcome030228 respiratory systemCase-Control StudiesInclusion and exclusion criteriaLength of stayBiomarker (medicine)Femalemedicine.symptombusinessPulmonary Pharmacology & Therapeutics
researchProduct

Leptin levels in induced sputum from patients with COPD are sensitive to smoking status

2005

researchProduct

Safety Considerations of Inhaled Corticosteroids in the Elderly

2014

Inhaled corticosteroids (ICSs) are widely used in the treatment of patients with chronic obstructive pulmonary diseases. However, high-dose regimens and long-term use of ICSs have the potential to cause a variety of local and systemic side effects such as candidiasis, cataracts, glaucoma, and osteoporosis. The use of ICSs can also be associated with the risk of bone fractures, diabetes mellitus and pneumonia. These ICS-related side effects are of particular importance in elderly patients due to the presence of comorbidities and age-related behavioral, cognitive, and psychological problems, which can all interact with inhaled treatment. We reviewed the available literature on the clinically …

Budesonidemedicine.medical_specialtyOsteoporosisSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionatePulmonary Disease Chronic ObstructivePharmacotherapyCataractsAdrenal Cortex HormonesDiabetes mellitusAdministration InhalationmedicineHumansPharmacology (medical)asthma corticosteroidsIntensive care medicineAgedCOPDbusiness.industrymedicine.diseaseAsthmaPneumoniaTreatment OutcomePhysical therapyGeriatrics and Gerontologybusinessmedicine.drugDrugs & Aging
researchProduct

A 15-Year-Old Boy with Anterior Chest Pain, Progressive Dyspnea, and Subcutaneous Emphysema of the Neck

2009

We describe the case of an adolescent who was admitted to the hospital because of sudden occurrence of chest pain, dyspnea and subcutaneous emphysema. On admission, physical examination revealed subcutaneous crepitations in the superior part of the rib cage, and auscultation of the chest showed widespread wheezing. The radiological assessment confirmed the diagnosis of pneumomediastinum and pneumothorax. A follow-up CT scan performed one week after the admission showed almost complete resolution of the radiological alterations. At the following visits, the patient was asymptomatic, but reported to have suffered from frequent episodes of rhinorrea, sneezing, nasal blockage, and sometimes, ch…

Spirometrymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCase Reportdyspnea atopy asthmaPhysical examinationSettore MED/10 - Malattie Dell'Apparato RespiratorioChest painmedicine.diseaserespiratory tract diseasesSurgeryPneumothoraxAnterior chestAnesthesiamedicineImmunology and AllergyPneumomediastinummedicine.symptombusinessSubcutaneous emphysemaAsthmaJournal of Allergy
researchProduct

Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics

2016

BACKGROUND: In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation. METHODS: Fifteen outpatients with moderate allergic asthma were recruited. Serum concentrations of periostin were assessed (ELISA) at baseline, and the frequency of asthma exacerbations was recorded during a one-year follow-up. RESULTS: Patients (M/F: 10/5, mean age of 47.6 ± 11.0 years) had mean ACQ score of 5.5 ± 4.2 and FEV1%pre…

Allergymedicine.medical_specialtyExacerbationSerum biomarkerPeriostinSettore MED/10 - Malattie Dell'Apparato RespiratorioBiochemistryAllergic inflammation03 medical and health sciences0302 clinical medicineInternal medicinemedicineAsthmatic patient030212 general & internal medicineAirway inflammation; Asthma; Exacerbation; Periostin; Serum biomarkerAsthmabusiness.industryResearchOrganic ChemistryExacerbationmedicine.diseaseSerum biomarker Asthma Periostin Exacerbation Airway inflammationAsthmaPeriostin030228 respiratory systemImmunologyBiomarker (medicine)businessAirwayAirway inflammation
researchProduct

Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophages.

1994

The purpose of this study was to evaluate the effect of theophylline on tumour necrosis factor-alpha (TNF-alpha) release by human blood monocytes (BMo), and rat BMo and alveolar macrophages (AM). BMo and AM were incubated in the absence or presence of theophylline, and the cell-free supernatants were harvested and tested for TNF-alpha activity by bioassay. Theophylline dose-dependently reduced TNF-alpha release by human BMo: significant inhibition was observed at 100 microns (41 +/- 5.9% of controls) and at 50 microns (59 +/- 4.8% of controls), while the inhibitory activity of theophylline at 10 microns (71 +/- 8.9% of controls) was not statistically significant. This activity was maximal a…

Pulmonary and Respiratory MedicineLipopolysaccharidesMalemedicine.medical_specialtyNecrosismedicine.drug_classmedicine.medical_treatmentGene ExpressionIn Vitro TechniquesTheophyllineBronchodilatorInternal medicineMacrophages AlveolarmedicineAnimalsHumansTheophyllineRats WistarDose-Response Relationship Drugbusiness.industryTumor Necrosis Factor-alphaMonocytemedicine.diseaseBlotting NorthernRatsmedicine.anatomical_structureEndocrinologyCytokineBronchial hyperresponsivenessLeukocytes MononuclearTumor necrosis factor alphaPulmonary alveolusmedicine.symptombusinessmedicine.drugThe European respiratory journal
researchProduct

Importance of Sniff Nasal Pressure (SNIP) as predictor of nocturnal respiratory function in amyotrophic lateral sclerosis (ALS)

2019

Background: In ALS, respiratory disturbances during sleep have an important role in the natural history of the disease. Diurnal and nocturnal blood gases are weakly correlated, but nocturnal respiratory disorders are difficult to predict. Aim: To evaluate if SNIP, an important parameter reflecting respiratory muscle strength, is related to nocturnal respiratory disorders and whether it contributes to predict nocturnal blood gas alterations in addition to daytime blood gas levels in ALS. Methods: Forty patients with ALS, after a daytime respiratory function evaluation, including arterial blood gases and SNIP, underwent a polysomnography with transcutaneous capnography (tcPCO2). The patients …

Capnographymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryPolysomnographyNocturnalmedicine.diseaseInternal medicineparasitic diseasesCardiologyRespiratory muscleMedicineArterial bloodRespiratory functionRespiratory systemAmyotrophic lateral sclerosisbusinessNoninvasive ventilatory support
researchProduct

Effect of age and asthma duration upon elastase and alpha1-antitrypsin levels in adult asthmatics

2003

In asthmatic subjects an imbalance between elastase and alpha1-antitrypsin (alpha1-PI) exists. This study aims to evaluate whether ageing per se affects the levels of elastase. Both young and elderly asthmatics with comparable severity and duration of disease, as well as young and elderly healthy subjects, underwent an induced sputum procedure to measure levels of elastase and alpha1-PI. The percentage of sputum neutrophils and eosinophils was higher in young and elderly asthmatics than in young and elderly controls. The levels of both total and active elastase were significantly higher in young and elderly asthmatics than in young and elderly controls, and directly correlated with the perc…

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtySputum CytologyPathologyAgingNeutrophilsDiseaseEosinophilSettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologyLeukocyte CountInternal medicineForced Expiratory VolumeMedicineHumansAsthmaAgedPancreatic Elastasebusiness.industryRespiratory diseaseElastaseNeutrophilSputumsocial sciencesMiddle Agedmedicine.diseasehumanitiesPathophysiologyAsthmaEosinophilsAgeingalpha 1-AntitrypsinAdult; Aged; Aging; Asthma; Eosinophils; Forced Expiratory Volume; Humans; Leukocyte Count; Middle Aged; Neutrophils; Pancreatic Elastase; Sputum; alpha 1-AntitrypsinSputummedicine.symptombusinessHuman
researchProduct

Correlati delle alterazioni della composizione corporea in pazienti anziani con BPCO

2006

researchProduct

Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D'Amato et al

2021

We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryHome therapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19030204 cardiovascular system & hematologyLMWH03 medical and health sciences0302 clinical medicinemedicineSteroidsbusinessLetter to the EditorHome therapy030215 immunology
researchProduct

FEV1/FEV6 and FEV6: sensitivity and specificity in detecting obstructive and restrictive disease of older patients

2008

spirometry elderlySettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics.

2016

Age represents an exclusion criterion in randomized clinical trials designed to test the efficacy and safety of inhaled drugs in asthma. As a consequence, data on efficacy and safety of inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) combinations in elderly asthmatics are scanty. Older age is associated with an increased proportion of comorbid conditions; in addition, all organ functions undergo a process of senescence, thus reducing their ability to metabolize the agents. Overall, these age-associated conditions may variably, and often unpredictably, affect the metabolism and excretion of respiratory drugs. However, pharmacological treatment of asthma does not follow specifi…

Druglong-acting β2 agonistmedicine.medical_specialtyasthma treatmentmedia_common.quotation_subjectPopulationReviewSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPharmacokineticsInhaled corticosteroidlawmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticseducationAdverse effectIntensive care medicineAsthmamedia_commoneducation.field_of_studyChemical Health and SafetyInhalationbusiness.industryaginglung functionGeneral Medicinemedicine.diseasecomorbidity030228 respiratory systemAnesthesiaPharmacodynamicslong-acting β2 agonistsinhaled corticosteroidsbusinessSafety ResearchTherapeutics and clinical risk management
researchProduct

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to thre…

2007

BACKGROUND: This randomised phase III study investigated if in responsive and stable disease (SD) stage IV patients after two courses of cisplatin and gemcitabine, single-agent gemcitabine (experimental arm) was not inferior in terms of overall survival (OS) to cisplatin-gemcitabine (standard arm). PATIENTS AND METHODS: Noninferiority was defined as an increase in the hazard of death (HR) < or = 1.33 in the experimental arm. From January 2001 to February 2004, 340 patients were registered and 250 were randomised. Cisplatin was administered on day 1 at 75 mg/m2 and Gemcitabine on days 1 and 8 at 1250 mg/m2 every 3 weeks. RESULTS: Response rate after two courses was 29%. The 1-year progressio…

OncologyMalemedicine.medical_specialtyRandomizationLung NeoplasmsTime Factorsmedicine.drug_classmedicine.medical_treatmentAntimetaboliteDeoxycytidineDrug Administration ScheduleInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalLung cancerNeoplasm StagingCisplatinChemotherapybusiness.industryHematologyMiddle Agedmedicine.diseaseSurvival AnalysisGemcitabineConfidence intervalGemcitabineSurgeryTreatment OutcomeOncologyFemaleCisplatinbusinessmedicine.drugFollow-Up StudiesAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Ageing and COPD affect different domains of nutritional status: the ECCE study

2010

Chronic obstructive pulmonary disease (COPD) and ageing may contribute to malnutrition. We aimed to explore whether COPD and ageing determine malnutrition in different manners. 460 stable COPD outpatients (376 males and 84 females) from the Extrapulmonary Consequences of COPD in the Elderly (ECCE) study database were investigated (age 75.0±5.9 yrs; forced expiratory volume in 1 s 54.7±18.3% predicted). Nutritional status was evaluated using the Mini Nutritional Assessment® (MNA) questionnaire. From the MNA, three scores exploring the domains of the nutritional status were calculated: body composition, energy intake and body functionality scores. Global Initiative for Chronic Obstructive Lun…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyAgingmedia_common.quotation_subjectAppetiteNutritional StatusSettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Pulmonary Disease Chronic ObstructiveInternal medicineSurveys and QuestionnairesActivities of Daily LivingmedicineHumansGeriatric Assessmentmedia_commonAgedCOPD Ageing nutritionGeriatricsAged 80 and overCOPDbusiness.industryMalnutritionAppetiteNutritional statusmedicine.diseaseNutrition SurveysObstructive lung diseaseMalnutritionAgeingPhysical therapyBody CompositionFemalebusinessEnergy Intake
researchProduct

VEGF is involved in local and systemic aspects of COPD.

2007

researchProduct

Light smoking and dependence symptoms in high-school students.

2005

Summary In high-school students, prevalence of smoking is high but few studies analyzed smoking in the student population according to nicotine content of smoked cigarettes and gender. We analyzed the responses to a questionnaire, including the modified Fagerstrom Tolerance Questionnaire (FTQ), administered to 555 students (382 males, 173 females) of a professional high school in Palermo, Italy, to assess the prevalence in both genders of: (1) smoking “light” and high nicotine (HN) cigarettes; (2) signs of nicotine dependence and (3) respiratory symptoms. Nicotine content of habitually smoked cigarettes was considered as “light” if ⩽0.8 mg; as high if >0.8 mg. Forty-four percent of students…

Pulmonary and Respiratory MedicineMaleFagerstrom tolerance questionnairemedicine.medical_specialtyNicotineAdolescentmedia_common.quotation_subjecteducationNicotine contentAddictionAdolescentsSmoking historyNicotineSex FactorsCigarette smokingSurveys and QuestionnairesmedicineHumansNicotine dependencePsychiatrymedia_commonPsychiatric Status Rating ScalesStudent populationbusiness.industryAddictionSmokingAge FactorsTobacco Use Disordermedicine.diseaseRespiration DisordersGanglionic StimulantsSchool environmentFemaleSmoking CessationbusinessDemographymedicine.drugRespiratory medicine
researchProduct

The Risk of Malnutrition Correlates with Perception of Dyspnea in COPD

2006

researchProduct

Asthma and metabolic syndrome: Current knowledge and future perspectives

2014

Asthma and obesity are epidemiologically linked; however, similar relationships are also observed with other markers of the metabolic syndrome, such as insulin resistance and dyslipidemia, which cannot be accounted for by increased body mass alone. Obesity appears to be a predisposing factor for the asthma onset, both in adults and in children. In addition, obesity could make asthma more difficult to control and to treat. Although obesity may predispose to increased Th2 inflammation or tendency to atopy, other mechanisms need to be considered, such as those mediated by hyperglycaemia, hyperinsulinemia and dyslipidemia in the context of metabolic syndrome. The mechanisms underlying the associ…

business.industryMinireviewsContext (language use)General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseBioinformaticsObesityAtopyInsulin resistancemedicineHyperinsulinemiaasthma obesityMetabolic syndromebusinessDyslipidemiaAsthmaWorld Journal of Clinical Cases
researchProduct

Challenges in the pharmacological treatment of geriatric asthma

2016

ABSTRACTAsthma in older populations is characterized by frequent comorbid conditions, which increase the risk of side effects and of detrimental interactions between respiratory and non-respiratory drugs. These observations lead to the need to manage asthma in older populations by applying a multidimensional assessment and a multidisciplinary treatment; therefore, we favor the use of the ‘geriatric’ term to define asthma in the elderly. Geriatric asthma is a complex disease, which may not necessarily imply that it is also complicated, although the two conditions may often coexist. On this basis, the switch from an organ-driven management to the holistic approach may be the key factor to att…

Agingmedicine.medical_specialtyComplex diseaseComorbidityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAnti-asthmatic AgentPharmacological treatmentOlder population03 medical and health sciences0302 clinical medicineMultidisciplinary approachAnimalsHumansMedicinePharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicinePsychiatryAgedAsthmabusiness.industryAge FactorsGeneral Medicinemedicine.diseaseComorbidityAsthmaInhaled treatment030228 respiratory systemAdherencePharmacology Toxicology and Pharmaceutics (all)businessExpert Review of Clinical Pharmacology
researchProduct

Are Asthmatics Enrolled in Randomized Trials Representative of Real-Life Outpatients?

2014

&lt;b&gt;&lt;i&gt;Background/Objective:&lt;/i&gt;&lt;/b&gt; This study was aimed at exploring to what extent populations enrolled in randomized controlled trials (RCTs) of inhalation combination treatment for mild/moderate asthma in adults are fully representative of ‘real-life' populations. The following is a retrospective analysis of the clinical records of outpatient subjects with an ascertained diagnosis of asthma. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; A retrospective analysis was performed. Stable conditions, such as smoking habit and chronic diseases other than asthma, were identified as exclusion criteria for RCTs. The selected criteria were then applied to asthmatic outpati…

AdultLung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsAdolescentResearch SubjectsAlternative medicineMEDLINECoronary Artery DiseaseAnxietySettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionYoung AdultRandomized controlled triallawmedicineHumansYoung adultAgedRandomized Controlled Trials as TopicRetrospective StudiesAsthmaAged 80 and overInhalationDepressionbusiness.industryPatient SelectionSmokingAge FactorsReal-lifeArrhythmias CardiacRetrospective cohort studyMiddle Agedmedicine.diseaseAsthmaRandomized controlled trialFemaleObservational studybusiness
researchProduct

Terapia del carcinoma polmonare non a piccole cellule in stadio IIIA e IIIB a buona prognosi

2004

researchProduct

LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space

2004

SUMMARY The pleural space is a virtual compartment between the lung and chest wall that becomes filled with fluid and inflammatory cells during a variety of respiratory diseases. Here, we study the potential role of the eicosanoid metabolite leukotriene B4 (LTB4) in disparate diseases leading to acute (pneumonia) or chronic (tuberculosis, cancer) inflammation of the pleural space. LTB4 concentrations were significantly higher in pleural fluid due to pneumonia, tuberculosis and cancer with respect to congestive heart failure and correlated with neutrophil elastase, which is used as an indication of state of activation of neutrophils in the pleural space. Moreover, pleural LTB4 was biological…

LipopolysaccharidesPathologyHot TemperatureNeutrophilsLeukotriene B4Gene ExpressionEpitheliumchemistry.chemical_compoundNeoplasmsClinical StudiesImmunology and AllergyMedicineRespiratory systemPancreatic ElastasebiologyNeutrophilMiddle Agedrespiratory systemChemotaxis Leukocytemedicine.anatomical_structureNeutrophil InfiltrationNeutrophil elastaseLTB4Pleuralipids (amino acids peptides and proteins)medicine.symptomAdultmedicine.medical_specialtyImmunologyInflammationGranulocyteLeukotriene B4HumansRNA MessengerTuberculosis PulmonaryAgedArachidonate 5-LipoxygenaseLungbusiness.industryPneumoniaMacrophage Activationmedicine.diseaserespiratory tract diseasesPleural EffusionPneumoniaEicosanoidchemistryImmunologybiology.proteinbusinessClinical and Experimental Immunology
researchProduct

Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study

2003

Objectives: Our objectives were to test the hypothesis that, in the geriatric population, chronic airway obstruction is associated with a higher prevalence of sleep disturbances; to identify the main correlates of sleep disturbances, and to verify whether asthma and COPD patients have different patterns of sleep disturbances. Methods: The EPESE questionnaire was administered to 734 patients aged 65 years and over with asthma or chronic obstructive pulmonary disease (cases) and 1237 individuals of comparable age who were free of respiratory disease but not of other chronic conditions (controls). Four sleep disturbances were quantified: difficulty in falling asleep, nocturnal awakening, morni…

Sleep Wake DisordersMalemedicine.medical_specialtyNeuropsychological TestsSettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionSeverity of Illness IndexCognition DisorderPulmonary Disease Chronic ObstructivePhysiology (medical)Internal medicineSurveys and QuestionnairesmedicineHumansSurveys and QuestionnaireSleep Wake DisorderWakefulnessDepression (differential diagnoses)Bronchodilator AgentAsthmaMorningAgedSleep disorderDepressive Disorder Majorbusiness.industryRespiratory diseasemedicine.diseaseSleep in non-human animalsBronchodilator AgentsSpirometryPhysical therapyGeriatric Depression ScaleFemaleNeuropsychological TestNeurology (clinical)businessCognition DisordersHuman
researchProduct

Mesotelioma pleurico maligno

2004

researchProduct

A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome: Table 1

2015

Rituximab is used as a steroid/calcineurin inhibitor-saving agent in patients with nephrotic syndrome. Safety is a crucial issue for justifying widespread use of the drug in this clinical setting. Rituximab-associated lung injury (RALI) is a severe and potentially life-threatening complication in oncohaematological and rheumatological patients, while it has only been anecdotally reported in association with idiopathic nephrotic syndrome (2 cases described, 1 with fatal outcome). We describe a benign form of RALI occurring in two adolescents treated with rituximab (single pulse of 375 mg/m2) for nephrotic syndrome. Before treatment, the patients were in good clinical condition while receivin…

Drugmedicine.medical_specialtyLungbusiness.industrymedia_common.quotation_subjectGeneral MedicineLung injurymedicine.diseaseGastroenterologyTacrolimusCalcineurinmedicine.anatomical_structureInternal medicineImmunologymedicineRituximabbusinessComplicationNephrotic syndromemedia_commonmedicine.drugBMJ Case Reports
researchProduct

Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma

2010

Background: Airway inflammation in asthma involves both large and small airways, and the combination of inhaled corticosteroids (ICS) and long acting beta-2 agonists (LABA) is the mainstay of therapy. Available inhaled combinations differ in terms of drug delivery to the lung and the ability to reach small airways. Aim: To evaluate whether treatment with an extra-fine inhaled combination provides additional effects vs a nonextra-fine combination on airway function. Methods: After a 1- to 4-week run-in period, patients with asthma were randomized to a double blind, double dummy, 12-week treatment with either extra-fine beclomethasone/formoterol (BDP/F) 400/24 lg daily or fluticasone propiona…

Fluticasone-Salmeterol Drug CombinationInhalationClosing capacitybusiness.industryImmunologyrespiratory systemmedicine.diseaseFluticasone propionaterespiratory tract diseasesAnesthesiamedicineImmunology and AllergyMethacholineSalmeterolFormoterolbusinessAsthmamedicine.drugAllergy
researchProduct

Aging and COPD affect different domains of nutritional status – The ECCE study.

2010

nutritionCOPDSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

2004

Pain is a highly distressing symptom for patients with advanced cancer. WHO analgesic ladder is widely accepted as a guideline for its treatment. Our aim was to describe pain prevalence among patients diagnosed with advanced non-small-cell lung cancer (NSCLC), impact of pain on quality of life (QoL) and adequacy of pain management. Data of 1021 Italian patients enrolled in three randomised trials of chemotherapy for NSCLC were pooled. QoL was assessed by EORTC QLQ-C30 and LC-13. Analgesic consumption during the 3 weeks following QoL assessment was recorded. Adequacy of pain management was evaluated by the Pain Management Index (PMI). Some pain was reported by 74% of patients (42% mild, 24% …

AdultMalecancer painCancer Researchmedicine.medical_specialtyLung NeoplasmsAnalgesicPainBone NeoplasmsSeverity of Illness Indexlaw.inventionClinicalPain Management IndexRandomized controlled trialQuality of lifelawCarcinoma Non-Small-Cell LungInternal medicineEpidemiologySeverity of illnessPrevalencemedicineHumansPain ManagementAgedPain MeasurementRandomized Controlled Trials as TopicAged 80 and overbusiness.industryGuidelineanalgesicMiddle AgedClinical triallung cancerItalyOncologyanalgesicsQuality of LifePhysical therapyFemalebusinessCancer painBritish Journal of Cancer
researchProduct

Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing

2014

Gemcitabine is a chemotherapy agent commonly used in the treatment of non-small cell lung cancer (NSCLC) that has been demonstrated to induce apoptosis in NSCLC cells by increasing functionally active Fas expression. The aim of this study was to evaluate the Fas/Fas ligand (FasL) system involvement in gemcitabine-induced lung cancer cell killing. NSCLC H292 cells were cultured in the presence or absence of gemcitabine. FasL mRNA and protein were evaluated by real-time PCR, and by Western blot and flow cytometry, respectively. Apoptosis of FasL-expressing cells was evaluated by flow cytometry, and caspase-8 and caspase-3 activation by Western blot and a colorimetric assay. Cytotoxicity of ly…

Cytotoxicity ImmunologicAntimetabolites AntineoplasticFas Ligand ProteinLung NeoplasmsImmunologychemical and pharmacologic phenomenaApoptosisSettore MED/10 - Malattie Dell'Apparato RespiratorioDeoxycytidineFas ligandFlow cytometryCarcinoma Non-Small-Cell LungCell Line TumormedicineImmunology and AllergyCytotoxic T cellHumansfas ReceptorLung cancerAutocrine signallingKiller Cells Lymphokine-ActivatedCaspase 8Lymphokine-activated killer cellmedicine.diagnostic_testChemistryCaspase 3Original Articlesmedicine.diseaseMolecular biologyGemcitabineGemcitabineApoptosisapoptosis cytotoxic lymphocytes non-small cell lung cancermedicine.drug
researchProduct

Asthmatics with high levels of serum surfactant protein D have more severe disease.

2016

Pulmonary surfactant is a mixture of lipids and surfactant-specific proteins that covers the alveolar surface, as well as the terminal conducting airways, lowering the surface tension at the air–liquid interface during breathing. The involvement of pulmonary surfactant in the pathophysiology of asthma has been suggested. An interesting working hypothesis is that the surface tension of the peripheral airways is altered in asthma, because the inflammatory process affects the structure and function of surfactant, leading to excessive airway narrowing and features of air trapping. We explored whether serum levels of surfactant protein D (SP-D) in asthmatics are related to the severity of the di…

0301 basic medicinePulmonary and Respiratory MedicineAdultMalesurfactantStatistics as TopicSevere diseasemacromolecular substancesSettore MED/10 - Malattie Dell'Apparato RespiratorioSeverity of Illness Index03 medical and health sciences0302 clinical medicineSeverity of illnessMedicineHumansAnti-Asthmatic Agentsbusiness.industrySmall airwaysSurfactant protein DReproducibility of Resultsrespiratory systemMiddle AgedPulmonary Surfactant-Associated Protein DAsthmaRespiratory Function Tests030104 developmental biology030228 respiratory systemImmunologyBiomarker (medicine)FemalebusinessBiomarkersThe European respiratory journal
researchProduct

Asthma in the elderly: a different disease?

2016

Key points Asthma in the elderly can be difficult to identify due to modifications of its clinical features and functional characteristics. Several comorbidities are associated with asthma in the elderly, and this association differs from that observed in younger patients. In clinical practice, physicians should treat comorbidities that are correlated with asthma (i.e. rhinitis or gastro-oesophageal reflux), assess comorbidities that may influence asthma outcomes (i.e. depression or cognitive impairment) and try to prevent comorbidities related to ­‘drug-associated side-effects (i.e. cataracts, arrhythmias or osteoporosis). “Geriatric asthma” should be the preferred term because it implies …

Pulmonary and Respiratory Medicinemedicine.medical_specialty2ReviewsPhysical examinationDiseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciences0302 clinical medicineEpidemiologymedicine030212 general & internal medicineIntensive care medicineDepression (differential diagnoses)Asthmalcsh:RC705-779medicine.diagnostic_testbusiness.industryPublic healthlcsh:Diseases of the respiratory systemAirway obstructionmedicine.diseaserespiratory tract diseasesClinical trial030228 respiratory systembusinessBreathe (Sheffield, England)
researchProduct

Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.

2010

CD94/NKG2A is an inhibitory receptor expressed by NK cells and cytotoxic lymphocytes and, upon activation by HLA-E, downregulates the cytolytic activities of these cells thus representing a tumour immune escape mechanism. This study was aimed at assessing whether cytotoxic lymphocytes (CD8+) and NK cells from malignant pleural effusions have a deregulated expression of CD94/NKG2A. The expression of membrane CD94/NKG2A and perforin was evaluated by flow-cytometry in CD8+ and NK cells from pleural effusions and autologous peripheral blood of cancer (n=19) and congestive heart failure (CHF) (n=11) patients. Intracellular CD94/NKG2A expression was evaluated by flow-cytometry in pleural effusion…

Cancer ResearchPleural effusionLymphocyteSettore MED/10 - Malattie Dell'Apparato RespiratorioCD8-Positive T-LymphocytesInterleukin 21Pleural diseaseNeoplasmsmedicineMalignant pleural effusionCytotoxic T cellHumansAgedHeart Failurebiologybusiness.industryPerforinCancerCD8-Positive T-LymphocyteMiddle Agedmedicine.diseaseNatural Killer T-CellPleural Effusion Malignantmedicine.anatomical_structureOncologyPerforinCase-Control StudiesImmunologybiology.proteinNeoplasmNatural Killer T-CellsTumor EscapebusinessCase-Control StudieNK Cell Lectin-Like Receptor Subfamily DHumanT-Lymphocytes CytotoxicEuropean journal of cancer (Oxford, England : 1990)
researchProduct